In the liver, these effects extend further: Reduced liver fat through mobilization of lipid stores Anti-inflammatory action that mitigates hepatocellular injury Fibrosis regression in patients with established scarring Cancer prevention potential, as chronic inflammation and fibrosis are major drivers of hepatocellular carcinoma This multifaceted benefit profile positions GLP-1s not merely as metabolic drugs, but as direct modulators of liver disease biology
Step 2: Pick your medication and plan
However, this was a small study, and more research is necessary to determine exactly how allulose impacts blood sugar
This dual-action approach supports a balanced microbiome, digestive health, and sustainable metabolic wellness
DECLARATIONS Authors contributions Controlled the study design and preparation of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Participated in planning and drafting the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Approved the final draft of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Availability of data and materials Not applicable
Read Patient Experiences with Kineret and check out our new MedWatch Safety Summary for Kineret derived from adverse event reports submitted directly to the FDA by patients, physicians, and other health professionals